Brief: Fivet Investment Management Ltd Reports 6.03% Stake In Inhibikase Therapeutics
11/01/2022 17:07
Jan 11 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* FIVET INVESTMENT MANAGEMENT LTD REPORTS 6.03% STAKE IN
INHIBIKASE THERAPEUTICS INC AS OF JANUARY 10, 2022 - SEC FILING
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share